The new agreements will guarantee as many as 76 million doses of NVX-CoV2373 from Gaithersburg, Maryland-based Novavax and 38 million doses of Ad26.COV2.S from New Brunswick, New Jersey-based Johnson & Johnson, Trudeau told reporters in Ottawa.
As we mentioned earlier, the Trump administration has indicated it will not be joining a WHO-backed coalition of 172 countries to share equitably any future vaccines against Covid-19 - and this has got some experts anxious.
That would represent a change of policy after the European Union executive had advised the 27 European Union governments not to purchase vaccines through the World Health Organization scheme deeming it slow, expensive and legally incompatible with the parallel European Union procurement programme, European Union officials said in July.
"In the weeks and months ahead, our government will continue to take the steps needed to make sure Canada gets a COVID-19 vaccine as soon as possible", the prime minister said.
If Canada could obtain a licence to make the AstraZeneca/Oxford vaccine here, that might speed up rollout, helped by another development announced Monday, said Attaran.
Africa's COVID-19 cases pass 1.25M as death toll approaches 30000
In McHenry County, the coroner's office will typically list COVID-19 as the primary cause of death when it's appropriate. COVID-19 risk in Jordan is high. "The people dying were not going to die but for the acquisition of COVID".
64% of South Africans would agree to taking a Covid-19 vaccine.
High-profile Covid-19 vaccines developed in Russian Federation and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say. Novavax is one of at least 23 companies working on solutions to COVID-19 amid a global pandemic.
"Concluding these contracts is not simply a matter of distributing a standard-form contract and having vaccine suppliers agree to our preferred terms", said Anand.
This is considered positive news in the ongoing global effort to develop a viable coronavirus vaccine.
"They are given the priority for vaccination because they are at the leading position".
As of Monday, Canada reported almost 128,000 cases of COVID-19 and some 9,150 deaths. It should be able to produce 250,000 monthly by November, said a news release.
The modified adenovirus type 5 (Ad5) viruses used in these vaccines grow in a human kidney cell line called HEK293 that was created by Canadian researcher Dr.
But upgrading cold storage infrastructure in regions outside the 25 most advanced countries, home to one-third of the global population, will pose an huge challenge, said Deutsche Post in its study, conducted with consultancy firm McKinsey.